The FDA/CMS Summit for Biopharmaceutical Executives 2014 will bring together leading pharmaceutical and biotechnology companies, payers, government officials and industry thought leaders to explore how the first year of the Affordable Care Act (ACA) exchanges has impacted drug manufacturers – and what’s to come next. The sessions will cover a broad array of topics, including drug pricing, drug coverage, reimbursement, biosimilars, and Medicare priorities, among others.
Manatt partner Deborah Bachrach has been asked to speak on a panel titled “Drug Coverage Under the ACA,” during which she and her co-panelists will discuss the lessons learned from the first year of expanded insurance coverage under the ACA, and the key changes to expect in 2015 and beyond. The panel will be moderated by Ian Spatz, a senior advisor with Manatt’s healthcare practice.
The conference will be held at the Fairmont Washington, D.C., Georgetown, on December 11-12, 2014. For more information, click here.